A randomized, double blind, parallel, placebo‐controlled study to investigate the efficacy of Lactobacillus paracasei N1115 in gut development of young children

In this clinical trial, the safety and effectiveness of Lactobacillus paracasei N1115 (LP N1115) were investigated as a potential probiotic to enhance gut development in young children born by caesarean section. Infants and young children between the ages of 6 months and 3 years were administered wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shijie, Xun, Yiping, Ahern, Grace J., Feng, Lili, Zhang, Dong, Xue, Yuling, Ross, Reynolds Paul, Doolan, Andrea M., Stanton, Catherine, Zhu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565250/
https://www.ncbi.nlm.nih.gov/pubmed/34760234
http://dx.doi.org/10.1002/fsn3.2533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565250/
https://www.ncbi.nlm.nih.gov/pubmed/34760234
http://dx.doi.org/10.1002/fsn3.2533

Ejemplares similares